These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 3341096)

  • 1. Characterization of secretion pattern of human prostatic acid phosphatase: a reassessment.
    Dejter SW; Erickson BA; Lynch JH
    Urology; 1988 Feb; 31(2):125-8. PubMed ID: 3341096
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Daily variability in human serum prostate-specific antigen and prostatic acid phosphatase: a comparative evaluation.
    Dejter SW; Martin JS; McPherson RA; Lynch JH
    Urology; 1988 Oct; 32(4):288-92. PubMed ID: 2459831
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circadian and day-to-day variation of prostatic acid phosphatase.
    Nissenkorn I; Mickey DD; Miller DB; Soloway MS
    J Urol; 1982 Jun; 127(6):1122-4. PubMed ID: 6177878
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diurnal variation of prostatic acid phosphatase (PAP) in urologic patients with nonprostatic disease.
    el-Shirbiny AM; Pawar HN; Nilson TE
    Urology; 1986 Apr; 27(4):302-5. PubMed ID: 3083554
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of manipulation of the prostate gland on serum prostate-specific acid phosphatase measured by radioimmunoassay.
    Vihko P; Lukkarinen O; Kontturi M; Vihko R
    Invest Urol; 1981 Mar; 18(5):334-6. PubMed ID: 6162819
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circadian rhythm in prostatic acid phosphatase (PAP): a potential tumor marker rhythm in prostatic cancer (PCa).
    Benvenuti M; Legnaioli M; Melone F; Taddei I; Tarquini B
    Chronobiologia; 1983; 10(4):383-6. PubMed ID: 6661985
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enzyme immunoassay of prostatic acid phosphatase after prostatic examination. Correlation with prostate size and immunopathology.
    el-Shirbiny AM; Shridhar P; al Adnani MS; Suresh LK
    Urology; 1988 Nov; 32(5):469-73. PubMed ID: 2460989
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Counterimmunoelectrophoretic studies of serum prostatic acid phosphatase.
    Romas NA; Hsu KC; Ng PY; Pitts M; Tomashefsky P; Tannenbaum M
    Prostate; 1980; 1(4):451-6. PubMed ID: 6169076
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prostatic acid phosphatase in serum and bone marrow in patients with prostatic carcinoma.
    Fossà SD; Skinningsrud A; Kaalhus O; Engeset A
    Br J Urol; 1983 Jun; 55(3):306-11. PubMed ID: 6850249
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship between diurnal rhythm of serum testosterone and two prostatic markers (PSA and PAP) in untreated prostate cancer.
    Akimoto S; Masai M; Shimazaki J
    Urology; 1994 Mar; 43(3):337-41. PubMed ID: 7510912
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Carcinoma of the prostate. II. Serum activity of acid phosphatase, prostatic acid phosphatase, LDH and its isoenzymes.
    Mráz J; Vrubel F; Hanselová M
    Int Urol Nephrol; 1979; 11(4):301-9. PubMed ID: 536179
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical assessment of solid phase immunoadsorbent assay of human prostatic acid phosphatase.
    Bauer HW; Schmeller NT
    Urology; 1984 Mar; 23(3):247-51. PubMed ID: 6199879
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bone scintigraphy, radiographic survey and prostatic acid phosphatase in patients with prostatic carcinoma. A comparison of sensitivity.
    Reikerås O; Due J; Sundsfjord JA
    Int Urol Nephrol; 1988; 20(1):51-4. PubMed ID: 3283071
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Secretion into and elimination from blood circulation of prostate specific acid phosphatase, measured by radioimmunoassay.
    Vihko P; Schroeder FH; Lukkarinen O; Vihko R
    J Urol; 1982 Jul; 128(1):202-4. PubMed ID: 6180187
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discriminative value of serum phosphatases in patients with prostatic carcinoma.
    Lämmel A; Krieg M; Becker H; Braun BE
    Urology; 1988 Oct; 32(4):293-300. PubMed ID: 2845624
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Measurement of serum prostatic acid phosphatase (PAP) by Delfia PAP Kit using europium and clinical evaluation in patients with prostate cancer].
    Akimoto S; Ohki T; Ichikawa T; Akakura K; Shimazaki J
    Hinyokika Kiyo; 1994 Nov; 40(11):987-93. PubMed ID: 7530404
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elevation of serum prostatic acid phosphatase levels after prostatic massage.
    Wadström J; Huber P; Rutishauser G
    Urology; 1984 Dec; 24(6):550-1. PubMed ID: 6209846
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A solid-phase immunoadsorbent assay for serum prostatic acid phosphatase.
    Lee CL; Killian CS; Murphy GP; Chu TM
    Clin Chim Acta; 1980 Feb; 101(2-3):209-16. PubMed ID: 7357745
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of prostate-specific antigen and prostatic acid phosphatase in untreated prostatic carcinoma and benign prostatic hyperplasia.
    Bogdanowicz JF; Bentvelsen FM; Oosterom R; Schroeder FH
    Scand J Urol Nephrol Suppl; 1991; 138():97-103. PubMed ID: 1723815
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum prostate-specific antigen: hourly change/24 hours compared with prostatic acid phosphatase.
    el-Shirbiny AM; Nilson T; Pawar HN
    Urology; 1990 Jan; 35(1):88-92. PubMed ID: 1688677
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.